Moonshots with Peter Diamandis

Investors should pivot from software toward "Hard Tech" leaders like SpaceX, though they must prepare for potential price volatility six months post-IPO when the massive employee lock-up period expires. To capitalize on the AI infrastructure bottleneck, prioritize "boring" electrical hardware providers like GE Vernova (GEV), Hitachi, and Siemens, which control the essential power transformers currently facing three-year wait times. As AI token costs hyper-deflate, shift focus away from raw intelligence providers and toward companies building high-value AI applications or autonomous "intent-based" agents. Due to increasing "Sovereign AI" risks and government export controls on firms like Anthropic, enterprises should hedge by investing in on-premise, open-weight models and the hardware that supports them. Monitor the potential merger between Tesla (TSLA) and SpaceX, as a consolidation of robotics, energy, and orbital compute would create a dominant, multi-planetary industrial powerhouse.

Accumulate Bitcoin (BTC) at the $60,000 support level to capitalize on institutional price targets ranging from $100,000 to $189,000 by 2026. Prepare for massive liquidity shifts into the AI sector as OpenAI and SpaceX AI approach historic IPOs with valuations exceeding $1.5 trillion. Consider SpaceX as a long-term infrastructure play, as its transition into "orbital compute" and satellite data centers positions it to become a dominant global hyperscaler. Monitor the longevity and biotech sectors for breakthroughs in epigenetic reprogramming, specifically following companies like New Limit as they aim for "Longevity Escape Velocity" by 2033. Investors should favor "Hard Tech" and AI infrastructure over traditional software, as the falling cost of AI inference may erode the competitive moats of standard software companies.

Prepare for a potential Anthropic IPO, which could reach a valuation of $1 trillion to $1.8 trillion as the company achieves recursive self-improvement with Claude writing over 80% of its own code. Investors should monitor Argentina as a high-growth emerging market play, as President Milei’s "Non-human Corporation" laws and zero-regulation stance aim to turn the country into a global hub for autonomous AI agents. Consider Bitcoin (BTC) a high-conviction buy on any dips below $60,000 to serve as a hedge against traditional currency volatility during this period of rapid technological disruption. Shift focus toward the "innermost loop" of AI infrastructure by investing in energy and next-generation compute substrates to capitalize on the massive hardware demand required to power autonomous models. Be cautious of broader market liquidity risks, as massive capital raises for private giants like SpaceX and Anthropic may force institutional sell-offs in other sectors to fund these positions.

Monitor the upcoming Anthropic IPO closely, as it offers the first direct retail access to a frontier AI lab with a projected valuation exceeding $1.8 trillion. Investors should consider NVIDIA (NVDA) as it expands beyond data centers into the consumer PC market with its new N1 and N1X chips to challenge Apple and Intel. Microsoft (MSFT) remains a high-conviction play for enterprise stability as it pivots to in-house AI models to reduce its dependency on OpenAI. In the biotech sector, look for exposure to "epigenetic reprogramming" and gene-editing firms like Verve Therapeutics, which are targeting massive longevity markets. The current U.S. regulatory environment of "voluntary review" provides a bullish tailwind for domestic AI leaders, prioritizing growth and market dominance over restrictive European-style compliance.

Investors should prioritize Alphabet (GOOGL) as a foundational AI play, as the company is currently developing the "physics engines" necessary to bridge the gap between digital intelligence and physical robotics by 2029. To capitalize on the essential hardware required for this exponential compute growth, NVIDIA (NVDA) remains a high-conviction hold for the critical 2026–2029 "AGI window." The most immediate financial disruption is occurring in the biotech and pharmaceutical R&D sectors, where AI-driven drug discovery is drastically reducing time-to-market for new treatments. Look for emerging opportunities in Brain-Computer Interface (BCI) and longevity services like Fountain Life, which are positioned to lead the transition toward merging biological and non-biological intelligence. Finally, consider shifting exposure away from traditional higher education toward Agile Education and Agentic AI platforms that automate complex software engineering and administrative tasks.

Investors should prioritize Amazon (AMZN) as it transforms its marketplace into an AI-driven platform, with its new shopping assistant converting users at 3.5x the rate of traditional search. For software development and complex technical workflows, Anthropic’s Opus 4.8 is currently the top-tier choice, significantly outperforming OpenAI in coding benchmarks and multi-agent management. IBM represents a high-conviction long-term play in hardware as it builds a $2 billion quantum foundry, positioning itself to become the "TSMC of Quantum" for the entire industry. The energy sector remains a critical macro theme, with Solar and Wind now outperforming natural gas; look for opportunities in companies connecting cheap renewables to AI data centers. Finally, shift long-term focus toward Robotics and Biotech as the next decade-long growth cycle, specifically targeting low-cost diagnostic hardware and humanoid manufacturing.

Investors should prioritize exposure to the "Magna Mopsta" 11, a group of essential AI and hard-tech leaders including NVIDIA (NVDA), Microsoft (MSFT), and Broadcom (AVGO). Monitor Tesla (TSLA) closely for a potential high-impact merger with SpaceX, which could consolidate Elon Musk’s AI and robotics assets into a unified entity valued up to $10 trillion. While NVIDIA remains the hardware leader, keep a watch on Cerebras as a rising "dark horse" challenger in the specialized chip sector. Look for private equity or secondary market opportunities in OpenAI and Anthropic, as they pivot toward high-margin enterprise software and coding agents. Finally, shift focus from the high cost of AI to the massive volume of usage, as falling token prices are driving a 30x to 50x explosion in demand across the X ecosystem.

Investors should prioritize companies building AI-native "digital twins" to replace legacy workflows, as traditional hierarchical firms face extreme disruption over the next 24 months. Be bearish on middle-management-heavy sectors like Oracle (ORCL) or SAP (SAP), which are vulnerable to leaner, agent-driven architectures that eliminate organizational drag. Look for high-conviction opportunities in autonomous software development platforms like Blitzy and AI-native customer service leaders like Klarna that are achieving massive headcount efficiency. Monitor the growth of Anthropic (Claude) and xAI (Grok) as they provide the foundational "intelligence stack" for small teams to disrupt high-margin industries. Focus on firms with proprietary data moats that are shifting human roles toward high-level curatorial judgment and dashboard oversight rather than manual coordination.

Investors should prepare for the SpaceX IPO, which aims to raise $75 billion at a valuation exceeding $1.75 trillion. The company is shifting focus toward AI infrastructure, highlighted by a $15 billion annual partnership with Anthropic for data center access. A massive strategic collaboration with Tesla (TSLA), dubbed Macrohard, aims to build a $22.7 trillion AI-run software ecosystem. Retail investors should monitor private equity platforms or wait for the public listing to gain exposure to the emerging "Microsoft of Space" infrastructure play. This offering represents a unique opportunity to invest in the backbone of space-based data centers and global mobile connectivity through Starlink.

Investors should consider Alphabet (GOOGL) as it leverages its massive 13-product ecosystem to deploy Gemini AI to billions, effectively defending its search moat against smaller disruptors. Watch for the newly public Cerebras Systems, which positions itself as the primary NVIDIA challenger with hardware optimized for the high-growth AI inference market. Monitor Meta and Google as they compete in the emerging Smart Eyewear sector, with a major shift toward audio-first ambient AI expected by 2025. High-conviction opportunities are also emerging in AI Infrastructure, specifically companies solving power and cooling bottlenecks for data centers as CapEx spending hits record highs. For long-term growth, focus on the "Verification Age" by investing in cryptographic and watermarking technologies like SynthID that secure AI-generated content.

Investors should prioritize exposure to the "Singularity Loop" by holding a basket of core chip stocks including Nvidia (NVDA), AMD, and TSMC (TSM), which have significantly outperformed the broader market. Anthropic’s massive revenue surge makes it a primary demand driver for Amazon (AMZN) and Nvidia hardware, while its $1.8B deal with Akamai (AKAM) highlights a high-growth infrastructure play. OpenAI’s upcoming "Super App" and 16-gigawatt power expansion pose a direct threat to Apple (AAPL) and Google (GOOGL), signaling a shift toward AI-driven operating systems. Energy and cooling infrastructure remain the ultimate bottlenecks; look for unpriced opportunities in liquid cooling components and energy providers supporting massive data center builds. As AI agents begin to automate the $1T legal and professional services sectors, traditional SaaS models are at risk, favoring companies that pivot to "outcome-based" pricing rather than seat licenses.

Investors should prioritize Alphabet (GOOGL) as it transitions into an AI infrastructure powerhouse, leveraging its industry-leading Cloud growth and custom TPU chips to create a dominant, vertically integrated moat. In the semiconductor space, maintain exposure to NVIDIA (NVDA) while considering Intel (INTC) as a strategic play on domestic manufacturing and national security tailwinds. Look beyond software to the "physical layer" of AI by investing in cooling systems, energy providers, and memory manufacturers like Samsung or SanDisk to capture the surge in data center demand. For private market exposure, focus on "orchestration layer" companies like Blitzy that provide autonomous enterprise solutions rather than simple model wrappers. Be cautious of OpenAI's delayed IPO (projected for 2027) and instead watch for Microsoft (MSFT) to develop in-house models as their exclusive partnership cools.

Investors should prioritize companies controlling the compute supply chain, such as data centers and specialized hardware providers, to capitalize on the massive compute shortfall expected by 2028. Eli Lilly (LLY) remains a high-conviction play as its new "triple agonist" peptide, Retatrutide, shows superior clinical results for weight loss and liver health compared to current market leaders. The investment value is shifting from pure software toward Physical AI, making humanoid robotics leaders like Tesla (TSLA), Figure AI, and 1X Technologies essential long-term holdings as they scale toward millions of units by 2030. Look for "pick and shovel" opportunities in the robotics sector, specifically in specialized insurance and maintenance services for autonomous fleets. Monitor Colossal Biosciences and related synthetic biology firms for breakthroughs in CRISPR technology, which will likely yield high-value applications in human healthcare and agriculture by 2028.

Investors should prioritize Google (GOOGL) for its unique vertical integration, as it designs proprietary TPU chips while simultaneously securing nearly one million NVIDIA GPUs to build the world’s largest AI cloud infrastructure. TSMC (TSM) remains the essential "bottleneck" play, as every major AI developer is entirely dependent on their fabrication capacity to meet surging hardware demand. For exposure to the private AI boom, look for secondary market opportunities in Anthropic, which is seeing massive revenue velocity and multi-billion dollar backing from Amazon and Google. The energy sector is a critical secondary play, specifically Nuclear and Small Modular Reactors (SMRs), which are required to power the next generation of "Gigawatt" data centers. In healthcare, Moderna (MRNA) is a high-conviction leader as AI-driven drug discovery transforms biology into a scalable engineering problem, evidenced by recent breakthroughs in mRNA cancer trials.

Investors should focus on GLP-1 leaders like Novo Nordisk (NVO) and Eli Lilly (LLY) as these drugs expand into massive heart and brain health markets beyond simple weight loss. Monitor clinical trial results from Life Biosciences regarding their ER100 gene therapy, which aims to reverse vision loss and cellular aging. For cardiovascular health, prioritize companies developing PCSK9 inhibitors as superior alternatives to statins for reversing plaque buildup. Look for AI-driven biotech startups that utilize transcriptomic data and agentic systems like Cadence to accelerate drug discovery timelines. When evaluating early-stage longevity investments, ensure the company has a high-conviction team and enough capital runway to survive the transition from academic research to clinical trials.

Investors should closely monitor Life Biosciences as it initiates human clinical trials for OSK gene therapy, targeting glaucoma and blindness with data expected by 2026. While gene therapies are currently high-cost, the most scalable opportunity lies in AI-driven small molecules (pills) that aim to mimic age-reversal effects for a mass-market audience. Watch for the "cocktail" of longevity molecules entering human trials via the Healthspan XPRIZE within the next few months as a major catalyst for the sector. In the consumer health space, there is growing demand for NMN, Resveratrol, and Nattokinase, the latter of which is being studied for its potential to reverse arterial plaque. For diversified exposure, focus on the Bio-IT sector, where Artificial Intelligence is significantly accelerating the timeline and reducing the cost of drug discovery for age-related diseases.

Investors should reduce exposure to traditional SaaS "wrappers" like Adobe (ADBE) and Figma, as frontier labs like Anthropic are now integrating these design and coding capabilities directly into their AI models. Keep a close watch on OpenAI for a potential IPO in late 2024 or 2025, as the company aggressively pivots from research toward enterprise profitability and "AI-native" professional workflows. Monitor the SpaceX and XAI ecosystem for a massive $60 billion acquisition of Cursor, signaling that AI-driven code generation is the primary high-value frontier for achieving AGI. Maintain long-term positions in data center infrastructure and U.S. Robotics, as private capital expenditure in these sectors is currently outpacing historic government programs like the Apollo mission. To hedge against geopolitical "system shocks," diversify away from semiconductor reliance on the Middle East, as a conflict in the Strait of Hormuz could cripple global chip manufacturing by cutting off critical supplies of helium and neon.

Investors should monitor Amazon (AMZN) and Apple (AAPL) as they leverage the Globalstar acquisition to challenge SpaceX in the "Direct-to-Cell" satellite market. Focus on companies holding S-band spectrum licenses, as these assets are becoming high-value acquisition targets for global mobile connectivity. In the AI sector, prioritize Anthropic’s Claude Opus 4.7 for enterprise workflow automation, specifically for its ability to analyze complex corporate documents and PDFs via expanded vision capabilities. Due to increasing data center bans in states like Maine, look for geographic arbitrage opportunities in pro-AI regions like New Hampshire and Texas that offer a "Right to Compute." Finally, consider exposure to modular nuclear or off-grid energy solutions, as data centers are increasingly forced to bypass the traditional power grid to meet massive energy demands.

Investors should prioritize NVIDIA (NVDA) as the essential "picks and shovels" play, as massive hardware spending by AI labs continues to drive corporate revenue gains. In the private markets, Anthropic is currently seeing triple the investor demand of OpenAI, making it the high-conviction "pure-play" competitor to watch for enterprise AI growth. Monitor the OpenAI fraud trial beginning April 27th, as any court-ordered restructuring or leadership changes involving Sam Altman could significantly devalue private holdings. For exposure to AI-driven drug discovery, look toward Eli Lilly (LLY) and its partnerships with AI-first firms like Insilico Medicine to capitalize on faster clinical trial success rates. Finally, Bitcoin (BTC) remains a high-conviction "hardened" asset for long-term holders, with major institutional buyers like MicroStrategy continuing multi-billion dollar accumulations despite future quantum computing concerns.

Prepare for a generational investment opportunity in SpaceX, which is targeting a $2 trillion IPO valuation driven by the massive profitability of Starlink and a 100% year-over-year revenue growth rate. Monitor secondary markets for Anthropic, as it has overtaken OpenAI in annual revenue and is positioned as the dominant enterprise AI leader ahead of a potential 2026 IPO. Consider Intel (INTC) as a strategic turnaround play due to its $25 billion "TerraFab" partnership with XAI, which aims to move leading-edge chip manufacturing to the U.S. and reduce dependency on TSMC. Investors should pivot away from traditional luxury commodities like De Beers diamonds, as lab-grown technology has triggered an 80% price collapse and destroyed the scarcity model. Look for emerging opportunities in Orbital Data Centers and Solar Robotics, which solve the terrestrial power and equipment shortages currently delaying 50% of land-based AI projects.